Skip to main content
. 2014 Dec 13;30(12):1972–1978. doi: 10.1093/ndt/gfu375

Table 1.

HLA characteristics of antibody and antigen that might affect clinical outcomes

Comment Reference
HLA antibody
 Concentration Not currently possible to measure antigen-specific concentration of antibody (see Figure 3)
 Antibody binding to HLA in solid phase assay (readout a combination of avidity and concentration) Measureable by microbead assays [2, 4]
 Class Mostly IgG, early reports of IgM mediated AMR and occurrence of IgA [20, 21]
 Subclass Early studies show heterogeneity in responses [21, 22]
 Affinity Measurement under investigation
 Glycosylation Measurement under investigation
 Cellular binding CDC and FC crossmatches
Endothelial binding
[2, 23]
Inhibitors
 Soluble HLA Early reports of methods to quantify
 HLA-E Early reports of correlation with clinical outcomes [24]
 Idiotypic antibodies Hard to measure with current tools but could be important [25]
Immune complexes
 HLA-sHLA immune complexes Not currently measureable